Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hans L Hillege

Showing results (1-10 of 325) with videos related to

Pageof 33
Sort By:
Nature Clinical Practice. Nephrology|August 26, 2006
Can an algorithm based on dipstick urine protein and urine specific gravity accurately predict proteinuria?Hans L Hillege
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|February 12, 2016
Tools and Techniques - Statistical. Estimating cumulative incidences in the presence of right-censoring and competing risks: an introduction with illustrations from the COACH studyDouwe Postmus, Biniyam G Demissei, Hans L Hillege
European Heart Journal|July 24, 2023
The European Medicines Agency assessment of mavacamten as treatment of symptomatic obstructive hypertrophic cardiomyopathy in adult patientsJ Hans DeVries, Alar Irs, Hans L Hillege
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|June 26, 2013
Probability elicitation to inform early health economic evaluations of new medical technologies: a case study in heart failure disease managementQi Cao, Douwe Postmus, Hans L Hillege, et al.
Journal of Cardiac Failure|February 3, 2009
Cardiac resynchronization therapy improves renal function: importance of forward and backward failureKevin Damman, Dirk J van Veldhuisen, Hans L Hillege
Circulation|March 2, 2005
Letter regarding article by Klausen et al, "very low levels of microalbuminuria are associated with increased risk of coronary heart disease and death independently of renal function, hypertension, and diabetes"Auke H Brantsma, Dick de Zeeuw, Hans L Hillege
Lancet (London, England)|August 18, 2009
Albuminuria in heart failure: a CHARMing new risk factor?Kevin Damman, Hans L Hillege, Dirk J van Veldhuisen
Journal of the American College of Cardiology|May 25, 2013
Reply: To PMID 23500300Dirk J van Veldhuisen, Tiny Jaarsma, Hans L Hillege
Statistics in Medicine|September 27, 2022
A simulated maximum likelihood procedure for analyzing imprecise trade-off thresholds between the benefits and harms of medicinesDouwe Postmus, Francesco Pignatti, Hans L Hillege, et al.
Kidney International. Supplement|August 20, 2005
The kidney, a cardiovascular risk marker, and a new target for therapyDick de Zeeuw, Hans L Hillege, Paul E de Jong
Pageof 33

Showing results (1-10 of 325) with videos related to

Sort By:
Pageof 33
Nature Clinical Practice. Nephrology|August 26, 2006
Can an algorithm based on dipstick urine protein and urine specific gravity accurately predict proteinuria?Hans L Hillege
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|February 12, 2016
Tools and Techniques - Statistical. Estimating cumulative incidences in the presence of right-censoring and competing risks: an introduction with illustrations from the COACH studyDouwe Postmus, Biniyam G Demissei, Hans L Hillege
European Heart Journal|July 24, 2023
The European Medicines Agency assessment of mavacamten as treatment of symptomatic obstructive hypertrophic cardiomyopathy in adult patientsJ Hans DeVries, Alar Irs, Hans L Hillege
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|June 26, 2013
Probability elicitation to inform early health economic evaluations of new medical technologies: a case study in heart failure disease managementQi Cao, Douwe Postmus, Hans L Hillege, et al.
Journal of Cardiac Failure|February 3, 2009
Cardiac resynchronization therapy improves renal function: importance of forward and backward failureKevin Damman, Dirk J van Veldhuisen, Hans L Hillege
Circulation|March 2, 2005
Letter regarding article by Klausen et al, "very low levels of microalbuminuria are associated with increased risk of coronary heart disease and death independently of renal function, hypertension, and diabetes"Auke H Brantsma, Dick de Zeeuw, Hans L Hillege
Lancet (London, England)|August 18, 2009
Albuminuria in heart failure: a CHARMing new risk factor?Kevin Damman, Hans L Hillege, Dirk J van Veldhuisen
Journal of the American College of Cardiology|May 25, 2013
Reply: To PMID 23500300Dirk J van Veldhuisen, Tiny Jaarsma, Hans L Hillege
Statistics in Medicine|September 27, 2022
A simulated maximum likelihood procedure for analyzing imprecise trade-off thresholds between the benefits and harms of medicinesDouwe Postmus, Francesco Pignatti, Hans L Hillege, et al.
Kidney International. Supplement|August 20, 2005
The kidney, a cardiovascular risk marker, and a new target for therapyDick de Zeeuw, Hans L Hillege, Paul E de Jong
Pageof 33